Cullen Frost Bankers Inc. Reduces Stake in Zoetis Inc. $ZTS

Cullen Frost Bankers Inc. lowered its holdings in Zoetis Inc. (NYSE:ZTS) by 3.5% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 43,870 shares of the company’s stock after selling 1,582 shares during the quarter. Cullen Frost Bankers Inc.’s holdings in Zoetis were worth $6,841,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Sound Income Strategies LLC lifted its stake in shares of Zoetis by 54.3% in the 2nd quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock valued at $67,000 after purchasing an additional 152 shares during the period. Canoe Financial LP lifted its stake in shares of Zoetis by 859.0% in the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock valued at $2,085,000 after purchasing an additional 11,975 shares during the period. Strs Ohio purchased a new position in shares of Zoetis in the 1st quarter valued at approximately $22,891,000. Tandem Investment Advisors Inc. lifted its stake in shares of Zoetis by 100.3% in the 1st quarter. Tandem Investment Advisors Inc. now owns 395,626 shares of the company’s stock valued at $65,140,000 after purchasing an additional 198,089 shares during the period. Finally, Soros Capital Management LLC lifted its stake in shares of Zoetis by 32.0% in the 1st quarter. Soros Capital Management LLC now owns 17,441 shares of the company’s stock valued at $2,872,000 after purchasing an additional 4,230 shares during the period. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

ZTS has been the subject of a number of research analyst reports. UBS Group lowered their target price on Zoetis from $165.00 to $158.00 and set a “neutral” rating for the company in a research note on Monday. Leerink Partnrs lowered Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Argus reaffirmed a “buy” rating and set a $190.00 price objective on shares of Zoetis in a research report on Tuesday, September 9th. Piper Sandler raised their price objective on Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research report on Monday, August 11th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Zoetis in a research report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $195.00.

Zoetis Stock Performance

Shares of ZTS opened at $147.10 on Thursday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. Zoetis Inc. has a one year low of $139.34 and a one year high of $189.98. The firm has a market capitalization of $65.19 billion, a P/E ratio of 25.32, a PEG ratio of 2.35 and a beta of 0.90. The business has a fifty day moving average of $148.47 and a 200 day moving average of $153.51.

Zoetis (NYSE:ZTS) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 EPS for the quarter, topping the consensus estimate of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The company had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the previous year, the company posted $1.56 earnings per share. Zoetis’s revenue was up 4.2% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, sell-side analysts anticipate that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 31st. This represents a $2.00 annualized dividend and a dividend yield of 1.4%. Zoetis’s payout ratio is presently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.